The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $11.84

Today's change+0.19 +1.63%
Updated June 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $11.84

Today's change+0.19 +1.63%
Updated June 23 4:00 PM EDT. Delayed by at least 15 minutes.

Endo International PLC up sharply

Endo International PLC closed up sharply Friday, rallying (U.S.)$0.19 or 1.63% to (U.S.)$11.84. Over the last five days, shares have gained 9.94%, but are down 28.11% for the last year to date. Shares have underperformed the S&P 500 by 40.63% during the last year.

Key company metrics

  • Open(U.S.) $11.60
  • Previous close(U.S.) $11.65
  • High(U.S.) $11.88
  • Low(U.S.) $11.46
  • Bid / Ask(U.S.) $11.22 / (U.S.) $11.95
  • YTD % change-28.11%
  • Volume6,429,244
  • Average volume (10-day)7,300,646
  • Average volume (1-month)6,626,951
  • Average volume (3-month)8,429,508
  • 52-week range(U.S.) $9.70 to (U.S.) $24.93
  • Beta0.60
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward3.31×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$14.81
Updated June 23 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-80.81%

Endo International PLC has a net profit margin of -80.81%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.65%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue1,0381,242884921
Total other revenue--------
Total revenue1,0381,242884921
Gross profit369485327289
Total cost of revenue669757557632
Total operating expense1,1054,536920969
Selling / general / administrative177213187193
Research & development43464551
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2163,52113193
Other operating expenses, total--------
Operating income-67-3,295-36-48
Interest income (expense), net non-operating-113-113-113-113
Gain (loss) on sale of assets--------
Other--------
Income before tax-177-3,406-145-165
Income after tax-165-3,333-191390
Income tax, total-12-7246-555
Net income-174-3,338-219344
Total adjustments to net income--------
Net income before extra. items-165-3,333-191390
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-165-3,333-191390
Inc. avail. to common incl. extra. items-174-3,338-219344
Diluted net income-174-3,338-219344
Dilution adjustment--------
Diluted weighted average shares223223223223
Diluted EPS excluding extraordinary itemsvalue per share-0.74-14.96-0.861.75
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.05-4.58-0.452.09